Literature DB >> 6325668

Effects of estradiol on norepinephrine-induced contraction, alpha adrenoceptor number and norepinephrine content in the female rabbit urethra.

B Larsson, K E Andersson, S Batra, A Mattiasson, C Sjögren.   

Abstract

Several studies have revealed that estrogen treatment increases the reactivity to catecholamines of various tissues. In the present study it was found that estrogen treatment caused an increased sensitivity to norepinephrine (NE) of the isolated female rabbit urethra. There was a 3-fold shift to the left of the concentration-response curve for longitudinal tension in perfused urethras and for tension in urethral ring preparations. Possible mechanisms for this increase in sensitivity were investigated by studying radioligand binding to the alpha adrenoceptors and by measuring the NE content of the urethras. Using [3H]dihydro-alpha-ergocryptine as a marker for alpha adrenoceptors, a more than 2-fold increase in the receptor number was found after estrogen treatment. This is suggested to be attributable to a selective increase in the number of alpha-2 adrenoceptors. No significant change was found in the affinity of [3H]dihydro-alpha-ergocryptine to the receptor. The total NE content in the urethra was not changed by estrogen treatment. However, if calculated per milligram of wet weight, the NE content was reduced to half in estrogen treated animals. It is suggested that in the rabbit urethra the estrogen-induced increased sensitivity to the contractant effects of NE, at least in part, is attributable to an increase in the number of postjunctional alpha-2 adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325668

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

Review 1.  Innovations in pharmacotherapy for stress urinary incontinence.

Authors:  Tracy W Cannon; Naoki Yoshimura; Michael B Chancellor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-20

2.  Pharmacotherapy for stress urinary incontinence.

Authors:  Tracy W Cannon; Michael B Chancellor
Journal:  Rev Urol       Date:  2003

3.  Direct effect of amezinium on rabbit urethra: effect of estrogen and progesterone treatment.

Authors:  M Ishigooka; T Hashimoto; Y Suzuki; O Ichiyanagi; I Sasagawa; T Nakada
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

4.  The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy.

Authors:  G Del Rio; C Carani; A Velardo; M Procopio; G Zizzo; P Savio; R Mantovani; P Marrama; E Ghigo
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

5.  Comparative studies on urethral function.

Authors:  M Habib; L Krasnopolsky; S Gaafar; R M Levin
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Increase by oestrogen of calcium entry and calcium channel density in uterine smooth muscle.

Authors:  S Batra
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

7.  Effect of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in the rat aorta.

Authors:  H L Andersen; J U Weis; B Fjalland; N Korsgaard
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 8.  Medical management of stress urinary incontinence: is there a future?

Authors:  Daniel J Caruso; Christopher S Gomez; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

9.  The effect of in vivo oestrogen pretreatment on the contractile response of rat isolated detrusor muscle.

Authors:  R A Elliott; C M Castleden; A Miodrag
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 10.  Pharmacotherapy for stress urinary incontinence : present and future options.

Authors:  Norman R Zinner; Stephanie C Koke; Lars Viktrup
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.